|
1.
|
|
21 p, 1.1 MB |
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
/
Kooij, J. J. S. (Amsterdam UMC) ;
Bijlenga, D. (Amsterdam UMC) ;
Salerno, L. (Institute of Neuroscience (Florència)) ;
Jaeschke, R. (Jagiellonian University Medical College (Polònia)) ;
Bitter, I. (DPC Naestved) ;
Balázs, J. (Vadaskert Child Psychiatric Hospital) ;
Thome, J. (St. George Hospital (Líban)) ;
Dom, Geert (Istanbul Institute pf Child amd Adolescent Psychiatry) ;
Kasper, S. (Medical University of Viena) ;
Nunes Filipe, C. (Universidade NOVA Lisboa) ;
Stes, S. (University Psychiatric Center (Bélgica)) ;
Mohr, Pavel (Charles University Prague) ;
Leppämäki, S. (Helsinki University Central Hospital) ;
Casas Brugué, Miquel ;
Bobes, Julio (Parenting and Special Education (Bélgica)) ;
Mccarthy, J. M. (King's College London) ;
Richarte, Vanesa (Hospital Universitari Vall d'Hebron) ;
Kjems Philipsen, A. (NPC Naestved (Dinamarca)) ;
Pehlivanidis, A. (National and Kapodistrian University of Athens Medical School) ;
Niemela, A. (Wellming Terveys Oy (Finlandia)) ;
Styr, B. (Jagiellonian University Medical College (Polònia)) ;
Semerci, B. (Hasan Kalyoncu University) ;
Bolea-Alamanac, B. (University of Toronto) ;
Edvinsson, Dan (Upsala University) ;
Baeyens, D. (Parenting and Special Education (Bélgica)) ;
Wynchank, D. (Amsterdam UMC) ;
Sobanski, E. (University Medical Center Mainz) ;
Philipsen, A. (University of Bonn) ;
Caci, Herve (Hospitaux Pediatriques de Nice CHU Lenval) ;
Mihailescu, I. (Alexandru Obregia Clinical Hospital of Psychiatria Bucharest) ;
Manor, I. (Geha MHC (Israel)) ;
Dobrescu, I. (Jagiellonian University Medical College (Polònia)) ;
Krause, J. (Outpatient Clinic (Alemanya)) ;
Fayyad, John (St. George University Medical Center (Líban)) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Foeken, K. (Vieux Chemin de Cagnes à La Gaude (França)) ;
Rad, F. (University of Medicine and Pharmacy "Carol Davila") ;
Adamou, M. (University of Huddersfield) ;
Ohlmeier, M. (Klinicum Kassel) ;
Fitzgerald, M. (Charles University Prague) ;
Gill, M. (Trinity College Dublin) ;
Lensing, M. (Antwerp University) ;
Motavalli Mukaddes, N. (Centrum Drobej Terapii (Polònia)) ;
Brudkiewicz, P. (Lund University) ;
Gustafsson, P. (Karolinska Institutet (Estocolm, Suècia)) ;
Tani, P. (High Security Hospital (Bélgica)) ;
Carpentier, Pieter Jan (Reinier van Arkel Mental Health Institute) ;
De Rossi, P. (Sapienza Univerity of Rome) ;
Delorme, R. (Robert Debré Hospital) ;
Markovska Simoska, S. (Macedonian Academy of Sciences and Arts) ;
Pallanti, S. (Standford University Medical Center) ;
Young, S. (Psychology Services Limited (Regne Unit)) ;
Bejerot, Susanne (Örebro University) ;
Lehtonen, T. (Neuropsykologkonsult Taina Lethonen (Suècia)) ;
Kustow, J. (Barnet Hospital) ;
Müller-Sedgwick, U. (University of Cambridge) ;
Hirvikoski, T. (Karolinska Institutet (Estocolm, Suècia)) ;
Pironti, V. (Cambridge Adult ADHD & ASD Clinic) ;
Ginsberg, Y. (Karolinska Institutet (Estocolm, Suècia)) ;
Félegeházy, Z. (Jagiellonian University Medical College (Polònia)) ;
García-Portilla, Maria-Paz (Universidad de Oviedo) ;
Asherson, Philip (King's College London) ;
Universitat Autònoma de Barcelona
Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. [...]
2019 -  10.1016/j.eurpsy.2018.11.001
European psychiatry, Vol. 56 (february 2019) , p. 14-34
|
|
|
2.
|
|
6 p, 285.2 KB |
Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?
/
Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ;
Bu, Eli Torild Hellandsjø (Bergen Clinics Foundation, Bergen, Norway) ;
Jellestad, Finn Konow (Department of Biological and Medical Psychology, University of Bergen, Norway) ;
van Emmerik-van Oortmerssen, Katelijne (The Netherlands Arkin, Amsterdam, The Netherlands) ;
Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Carpentier, Pieter Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Franck, Johan (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Konstenius, Maija (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Kaye, Sharlene (National Drug and Alcohol Research Centre, UNSW Australia, Sydney, Australia) ;
Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ;
Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ;
Fatséas, Melina (Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France) ;
Auriacombe, Marc (Laboratoire de psychiatrie Département d'addictologie, Université de Bordeaux, Bordeaux, France) ;
Johnson, Brian (Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Faraone, Stephen V. (Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Levin, Frances R. (Columbia University/the New York State Psychiatric Institute, New York, USA) ;
Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Schoevers, Robert A. (Dept of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Koeter, Maarten W. J. (Amsterdam UMC. University Medical Center) ;
van den Brink, Wim (Amsterdam UMC. University Medical Center) ;
Moggi, Franz (Bern University Hospital) ;
Møller, Merete (Sykehuset Østfold, Norway) ;
van de Glind, Geurt (Trimbos Instituut, ICASA Foundation, The Netherlands) ;
Universitat Autònoma de Barcelona
The prevalence of ADHD among patients with substance use disorder (SUD) is substantial. This study addressed the following research questions: Are early developmental, temperamental and educational problems overrepresented among SUD patients with ADHD compared to SUD patients without ADHD? Do this comorbid group receive early help for their ADHD, and are there signs of self-medicating with illicit central stimulants? An international, multi-centre cross-sectional study was carried out involving seven European countries, with 1205 patients in treatment for SUD. [...]
2015 - 10.1016/j.abrep.2015.03.001
Addictive Behaviors Reports, Vol. 2 (march 2015) , p. 13-18
|
|
|
3.
|
|
20 p, 358.8 KB |
Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients : Results from an international multi-center study exploring DSM-IV and DSM-5 criteria
/
van de Glind, Geurt (Amsterdam UMC. University Medical Center) ;
Koeter, Maarten W. J. (Amsterdam UMC. University Medical Center) ;
van Emmerik-van Oortmerssen, Katelijne (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Carpentier, Pieter Jan (Reinier van Arkel groep, 's-Hertogenbosch, The Netherlands) ;
Kaye, Sharlene (National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia) ;
Degenhardt, Louisa (Melbourne School of Population and Global Health, University of Melbourne, Australia) ;
Skutle, Arvid (Bergen Clinics Foundation, Bergen, Norway) ;
Franck, Johan (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Bu, Eli Torild Hellandsjø (Bergen Clinics Foundation, Bergen, Norway) ;
Moggi, Franz (University Hospital of Psychiatry Bern and Department of Psychology, University of Fribourg, Fribourg, Switzerland) ;
Dom, Geert (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Verspreet, Sofie (Collaborative Antwerp Psychiatry Research Institute (Anvers, Bèlgica)) ;
Demetrovics, Zsolt (Institute of Psychology, Eötvös Loránd University, Budapest, Hungary) ;
Kapitány-Fövény, Máté (Nyíro Gyula Hospital Drug Outpatient and Prevention Center, Budapest, Hungary) ;
Fatséas, Melina (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ;
Auriacombe, Marc (Laboratoire de psychiatrie, Sanpsy CNRS USR 3413, Université de Bordeaux, and Département d'addictologie, CH Ch. Perrens/CHU de Bordeaux, Bordeaux, France) ;
Schillinger, Arild (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ;
Møller, Merete (Østfold Hospital Trust, Department for Substance Abuse Treatment, Norway) ;
Johnson, Brian (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Faraone, Stephen V. (Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Casas Brugué, Miquel (Hospital Universitari Vall d'Hebron) ;
Allsop, Steve (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Carruthers, Susan (National Drug Research Institute/Curtin University of Technology, Perth, Australia) ;
Schoevers, Robert A. (Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands) ;
Wallhed, Sara (Stockholm Centre for Dependency Disorders, Sweden) ;
Barta, Csaba (Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary) ;
Alleman, Peter (Alcohol Treatment Research, Kirchlindach and Ellikon, Switzerland) ;
Levin, Frances R. (Columbia University/New York State Psychiatric Institute, New York City, NY, USA) ;
van den Brink, Wim (Amsterdam UMC. University Medical Center) ;
Konstenius, Maija (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Universitat Autònoma de Barcelona
Available studies vary in their estimated prevalence of attention deficit/hyperactivity disorder (ADHD) in substance use disorder (SUD) patients, ranging from 2 to 83%. A better understanding of the possible reasons for this variability and the effect of the change from DSM-IV to DSM-5 is needed. [...]
2013 - 10.1016/j.drugalcdep.2013.09.026
Drug and alcohol dependence, Vol. 134 (october 2013) , p. 158-166
|
|
|
4.
|
|
24 p, 525.7 KB |
European consensus statement on diagnosis and treatment of adult ADHD : The European Network Adult ADHD
/
Kooij, Sandra J. J. (PsyQ, psycho medische programma (Països Baixos)) ;
Blackwell, Andrew (Addenbrookes Hospital (Cambridge, Regne Unit)) ;
Caci, Herve (Hôpitaux Pédiatriques CHU-Lenval (Niça, França)) ;
Casas Brugué, Miquel (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Carpentier, Pieter Jan (Reinier van Arkel Groep (Països Baixos)) ;
Edvinsson, Dan (Department of Neuroscience/Psychiatri Ulleråker (Uppsala, Suècia)) ;
Fayyad, John (Balamand University (Beirut, Líban)) ;
Foeken, Karin (Institut A Tzanck (Mougins, França)) ;
Fitzgerald, Michael (Trinity College Dublin. Department of Psychiatry) ;
Gaillac, Veronique (Clinique des Maladies Mentales et de l'Encéphale (Paris, França)) ;
Ginsberg, Ylva (Affektiva mottagningen (Estocolm, Suècia)) ;
Henry, Chantal (CH Charles Perrens. Département de Psychiatrie Adulte (Burdeus, França)) ;
Krause, Johanna (Private clinic for psychiatry and psychotherapy (Ottobrunn, Alemanya)) ;
Lensing, Michael B. (Oslo University Hospital (Oslo, Noruega)) ;
Manor, Iris (Tel-Aviv University. Faculty of Medicine (Tel-Aviv, Israel)) ;
Niederhofer, Helmut (Regional Hospital of Bolzano. Department of Child Psychiatry (Bolzano, Itàlia)) ;
Nunes-Filipe, Carlos (New University of Lisbon (Lisboa, Portugal)) ;
Ohlmeier, Martin D. (Hannover Medical School. Department of Psychiatry, Social Psychiatry and Psychotherapy (Alemanya)) ;
Oswald, Pierre (Université Libre de Bruxelles. Department of Psychiatry) ;
Pallanti, Stefano (Florence University. Department of Neurosciences (Florència, Itàlia)) ;
Pehlivanidis, Artemios (University of Athens Medical School (Atenes, Grècia)) ;
Ramos-Quiroga, Josep Antoni (Hospital Universitari Vall d'Hebron) ;
Rastam, Maria (Lund University. Department of Clinical Sciences (Lund, Suècia)) ;
Ryffel-Rawak, Doris ;
Stes, Steven (Catholic University Leuven (Bèlgica)) ;
Asherson, Philip (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Bejerot, Susanne (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience)
Background: Attention deficit hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that persists into adulthood in the majority of cases. The evidence on persistence poses several difficulties for adult psychiatry considering the lack of expertise for diagnostic assessment, limited treatment options and patient facilities across Europe. [...]
2010 - 10.1186/1471-244X-10-67
BMC Psychiatry, Vol. 10, N. 67 (September 2010) , p. 1-24
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
